Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors Presented at Maxim Virtual Growth Conference, March 2022
https://renovorx.com/wp-content/uploads/2022/03/RNXT-Investor-Presentation_2022-03-14_2-animation-removed.pdf